In malignant CMTs, CKs are typically overexpressed in carcinomas and serve as highly valuable tumour markers in oncology (3); consistent CK18 expression has been observed in canine mammary gland carcinomas (17, 24, 31). The gene discussed is KRT18; the disease is carcinoma.